Four principles stand out: Nutrient density as north star: When people eat less, every bite matters more
Semaglutide , originally developed to treat type 2 diabetes, has quickly gained attention for its powerful role in medical weight loss
Research, including recent findings from the SELECT trial, indicates that GLP-1 agonists like semaglutide can significantly reduce the risk of major cardiovascular events, such as heart attacks and strokes, especially in individuals with obesity but without diabetes
While freezing can preserve some peptides, the freeze-thaw cycle can be incredibly damaging to complex molecules like this one
Studies on patients taking GLP-1 RAs have demonstrated increased gastric residue on esophagogastroduodenoscopy [16]
Probiotics have been shown to be potentially effective in reducing diarrhea duration and frequency, though these data were gathered on children and may not be applicable to adults on semaglutide